Patent Assignment
Reel/Frame 051852/0526
Confirmatory License
Recorded: 2019-11-26
Pages: 2
Assignor
UNIVERSITY OF UTAH
Executed: 2018-01-29
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property
(1)
Treatment of Focal Segmental Glomerular Sclerosis (Fsgs) Using Therapeutically Effective Oral Doses of 10-Nitro-9(E)-Octadec-9-Enoic Acid
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2018
From: JORKASKY, DIANE
To: COMPLEXA INC.
Reel/Frame 045769/0562 →
Assignment of Assignor's Interest
Nov 26, 2019
From: YANG, TIANXIN
To: THE UNIVERSITY OF UTAH
Reel/Frame 051121/0499 →
Assignment of Assignor's Interest
Nov 26, 2019
From: THE UNIVERSITY OF UTAH
To: THE UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 051122/0883 →
Assignment of Assignor's Interest
Dec 17, 2020
From: COMPLEXA, INC.
To: IMARA INC.
Reel/Frame 054680/0857 →